Enorna Biotechnology is a China-based mRNA CRDMO centered on lipid nanoparticle (LNP) delivery, offering end-to-end services from sequence design to commercial manufacturing, including plasmid DNA, RNA drug substance, LNP/tLNP formulation, fill-finish and lyophilization. Within roughly a year of operation the company has delivered more than 150 GMP-grade batches to over 100 clients, including multinational pharmaceutical companies, across programs in gene editing, in vivo CAR, personalized cancer vaccines and protein replacement. It is building GMP capacity and overseas business to serve as a global nucleic-acid manufacturing partner.
1
Round
1
Industry
5
Tags
Oct 29, 2026
Latest raise
Funding activity · 1 round
Oct 29, 2026
CNY 100M
Seed
Led by Yida Capital (毅达资本)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
